The report will be delivered in 2-3 business days.

Colorectal Cancer Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Starting Price : $ 4000.00 $3200.00 | Pages : 200 | Published : September 2020 | SKU CODE : 7218 | Format :


The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting large intestine and the rectum. They are also named, colon tumor or rectal cancer depending upon where they begin.

The global colorectal cancer drugs market is expected to decline from $6.9 billion in 2019 to $5.9 billion in 2020 at a compound annual growth rate (CAGR) of -15.3%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. Hospitals across the world have postponed the chemo treatments for cancer patients due to covid positive cases in the hospitals. The sessions are delayed or postponed to prevent patients and staff from unnecessary exposure. The cancer treatment can lower the patient`s ability to fight infection. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 3.1% from 2021 and reach $7.6 billion in 2023.

North America was the largest region in the colorectal cancer drugs market in 2018. This region is expected to remain the largest during the next five years. The colorectal cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

The number of colorectal cancer worldwide has been increasing. According to the American Cancer Society (ACS) estimates, there will be around 101,420 new cases of colon cancer and around 44,180 new cases of rectal cancer that would be registered in the USA in 2019. The diagnosed incident cases of colorectal cancer are expected to increase by 27.3% to 672,400 cases by 2037. The reason for this increase can be attributed to factors such as low-fiber diet, obesity, consumption of alcohol and tobacco amongst others. The increase in number of colorectal cases will add to the overall size of the global colorectal cancer drugs market.

Increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body’s immune system to fight cancer rather than chemical drugs which reduces the body’s immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective. For example, some targeted therapies that have been approved to treat colorectal cancer include bevacizumab, cetuximab and panitumumab. The advantages of biologics drugs and targeted therapies over conventional chemical drugs might negatively influence the market.

Targeted therapies have already begun to extend the lifespan of metastatic Colorectal cancer patients compared with chemotherapy-only therapy. Target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells. Opdivo and Keytruda are examples of targeted therapies.  

The colorectal cancer industry is governed by regulatory framework laid down by agencies such as US Food and Administration Agency (FDA), European Medicines Agency (EMA), American Society of Clinical Oncology (ASCO), and others. For instance, FDA`s recommendation for colorectal cancer drugs industry in the form of guidelines are mentioned within the CFR `s (Code for Federal Regulations) title number 21 under part 312, that contains sub-parts from A to I. The sub-part E deals with the procedures designed to push the development, evaluation, and marketing of drugs related to therapies aimed to treat persons with life-threatening and illnesses such as colorectal cancer. It also includes guidelines for the monitoring and evaluation of clinical trials of colorectal cancer drugs and other cancer drugs by agency officials to determine whether new treatments are safe and effective, or better than existing treatments.

In April 2019, Bristol-Myers Squibb Company, an American pharmaceutical company got the approval to acquire Celgene corporation for $74 billion. The transaction is expected to create a leading specialty company which would address the needs of patients with cancer, inflammatory and immunologic disease and cardiovascular disease through high-value innovative medicines and leading scientific capabilities.  Celgene corporation, a company that develops medicines for cancer and inflammatory disorders, was founded in 1996 and has its headquarters in the USA.

The major players covered in the global colorectal cancer drugs market are Merck & Co. Inc, Roche, Sanofi, Amgen, PFIZER, INC., Abbott Laboratories, Taiho Pharma, Novartis, GlaxoSmithKline, Onyx, TAKEDA PHARMACEUTICALS, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Eli Lilly, RANDOX LABORATORIES, Suzhou Zelgen Biopharmaceuticals,  Beckman Coulter, Inc, Regeneron, EDP Biotech, Genomic Tree, Metabiomics Corporation, SIEMENS HEALTHCARE, Suzhou Zelgen Biopharmaceuticals, Sumitomo Dainippon Pharma,  EPIGENOMICS.

The countries covered in the global colorectal cancer drugs market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia.

The regions covered in the global colorectal cancer drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global colorectal cancer drugs market is segmented -
1) By Type : Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL
1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators.
2) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Others.

    1. Executive Summary

    2. Colorectal Cancer Drugs Market Characteristics

    3. Colorectal Cancer Drugs Market Size And Growth

    3.1. Global Colorectal Cancer Drugs Historic Market, 2015-2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Colorectal Cancer Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Colorectal Cancer Drugs Market Segmentation

    4.1. Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Vascular Endothelial Growth Factor (VEGF) Inhibitors

    Epidermal Growth Factor Receptor (EGFR) Inhibitors

    Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors

    BRAF or MEK Inhibitors

    Tyrosine Kinase (TKI) Inhibitors

    Immunomodulators

    4.2. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospitals Pharmacies

    Retail Pharmacies

    Others

    5. Colorectal Cancer Drugs Market Regional And Country Analysis

    5.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Colorectal Cancer Drugs Market  

    6.1. Asia-Pacific Colorectal Cancer Drugs Market Overview  

    6.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Colorectal Cancer Drugs Market  

    7.1. China Colorectal Cancer Drugs Market Overview  

    7.2. China Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Colorectal Cancer Drugs Market  

    8.1. India Colorectal Cancer Drugs Market Overview  

    8.2. India Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Colorectal Cancer Drugs Market  

    9.1. Japan Colorectal Cancer Drugs Market Overview  

    9.2. Japan Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Colorectal Cancer Drugs Market  

    10.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Colorectal Cancer Drugs Market  

    11.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Colorectal Cancer Drugs Market  

    12.1. South Korea Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Colorectal Cancer Drugs Market  

    13.1. Western Europe Colorectal Cancer Drugs Market Overview

    13.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Colorectal Cancer Drugs Market  

    14.1. UK Colorectal Cancer Drugs Market Overview

    14.2. UK Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Colorectal Cancer Drugs Market  

    15.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Colorectal Cancer Drugs Market  

    16.4. France Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Colorectal Cancer Drugs Market  

    17.1. Eastern Europe Colorectal Cancer Drugs Market Overview

    17.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Colorectal Cancer Drugs Market  

    18.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Colorectal Cancer Drugs Market  

    19.1. North America Colorectal Cancer Drugs Market Overview

    19.2. North America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Colorectal Cancer Drugs Market  

    20.1. USA Colorectal Cancer Drugs Market Overview

    20.2. USA Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Colorectal Cancer Drugs Market  

    21.1. South America Colorectal Cancer Drugs Market Overview

    21.2. South America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Colorectal Cancer Drugs Market  

    22.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Colorectal Cancer Drugs Market  

    23.1. Middle East Colorectal Cancer Drugs Market Overview

    23.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Colorectal Cancer Drugs Market  

    24.1. Africa Colorectal Cancer Drugs Market Overview

    24.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

    25.1. Colorectal Cancer Drugs Market Competitive Landscape

    25.2. Colorectal Cancer Drugs Market Company Profiles

    25.2.1. Merck & Co. Inc

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Roche

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Sanofi

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Amgen

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. PFIZER, INC.

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

    27. Colorectal Cancer Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2019-2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: China, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: India, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Japan, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Australia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: UK, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Germany, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: France, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Russia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: North America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: USA, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: South America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Africa, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: Merck & Co. Inc Financial Performance
  • Table 46: Roche Financial Performance
  • Table 47: Sanofi Financial Performance
  • Table 48: Amgen Financial Performance
  • Table 49: PFIZER, INC. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2019-2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: China, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: China, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: India, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: India, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: Japan, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Australia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: South Korea, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: UK, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Germany, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: France, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: France, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Russia, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: North America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: USA, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: South America, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: Brazil, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Middle East, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Africa, Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: Merck & Co. Inc Financial Performance
  • Figure 46: Roche Financial Performance
  • Figure 47: Sanofi Financial Performance
  • Figure 48: Amgen Financial Performance
  • Figure 49: PFIZER, INC. Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)